Research & Development

The Oxyless bloodline is a CE Mark product, and has been used in over 15,000 dialysis procedures.

The design of the Oxyless arterial expansion chamber leads to the reduction in the contact between blood and air by 99.1%. This is brought about by:

1. A reduction in surface area and,
2. Improved blood flow dynamics

The Oxyless bloodline has been developed in a range of configurations for use on all traditional dialysis machine types, including those used in the USA, Europe and Asia. It is a CE mark product and has been used in over 70,000 dialysis procedures worldwide.

The Oxyless bloodline has evidenced significant positive results across a European Clinical Audit.